Titan Pharmaceuticals Inc...

NASDAQ: TTNP · Real-Time Price · USD
5.18
0.25 (5.07%)
At close: Aug 18, 2025, 3:59 PM
5.20
0.39%
After-hours: Aug 18, 2025, 07:06 PM EDT

Titan Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a 1K 60K 1.53M
Cost of Revenue
n/a n/a 196K 199K
Gross Profit
n/a 1K -136K 1.33M
Operating Income
-4.56M -7.28M -10.23M -9.35M
Interest Income
n/a 5K 53K 1K
Pretax Income
-4.71M -5.57M -10.21M -8.78M
Net Income
-4.71M -5.57M -10.18M -8.11M
Selling & General & Admin
4.56M 5.55M 6.03M 4.99M
Research & Development
n/a 1.91M 4.76M 5.69M
Other Expenses
n/a -183K -497K -84K
Operating Expenses
4.56M 7.28M 10.29M 10.68M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
n/a 7.46M 10.29M 10.88M
Income Tax Expense
n/a n/a -29K -662K
Shares Outstanding (Basic)
899K 752K 671.7K 2M
Shares Outstanding (Diluted)
899K 752K 671.7K 2M
EPS (Basic)
-5.23 -7.41 -15.15 -4.06
EPS (Diluted)
-5.23 -7.41 -15.15 -4.06
EBITDA
-4.7M -7.17M -10.04M -9.13M
EBIT
-4.71M -7.28M -10.23M -9.35M
Depreciation & Amortization
n/a 112K 196K 221K